AI-Powered Ultrasound System Matches Rheumatologists in Arthritis Detection

Automated Ultrasound System for Rheumatoid Arthritis Assessment

A new study shows that an automated ultrasound scanning system using artificial intelligence performs similarly to expert rheumatologists in assessing hand joints of patients with rheumatoid arthritis (RA).

Key Features of the System

• Ultrasound Scanner: The ARTHUR device scans 11 joints per hand.
• AI Software: DIANA analyzes the ultrasound images, scoring disease activity.
• EULAR Standards: The system classifies RA according to European Alliance of Associations for Rheumatology and Outcome Measures in Rheumatology standards.

Current Use and Development

The Danish company ROPCA created this system, which has been approved in Europe and is in use at clinics in Denmark, Germany, Switzerland, and Austria. The system can help early detection and monitoring of arthritis, especially in areas with limited rheumatological expertise.

Benefits for Patients

Dr. Søren Just, co-founder of ROPCA, emphasizes that this technology can provide timely assessments for patients experiencing hand pain. It can distinguish between RA and osteoarthritis and offer immediate results, which traditionally could take months.

Study Overview

In the study, 30 RA patients were scanned twice by ARTHUR, with results compared to a scan from a human rheumatologist. An expert determined the “ground truth,” or the most severe case of disease activity.

Results

• Patient Profiles: The average age of participants was 65, with most having a disease duration of 11 years.
• Scanning Performance: ARTHUR successfully scanned 660 joints, with a success rate for scans of about 86%.
• Agreement with Experts: The system’s performance matched that of human rheumatologists well, with close agreements on disease activity scores.

Conclusion

This automated system shows potential for effective and efficient RA assessments, offering consistent performance without human fatigue. The technology can help provide quick diagnoses and facilitate patient access to care. The project has even employed a mobile unit for outreach, aiding in the screening of patients in remote areas.

The precision of ARTHUR and DIANA offers a promising future for rheumatology, allowing for improved patient outcomes through innovations in medical technology.